Elgia Therapeutics
elgiatherapeutics.com
Drug Discovery
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$2.3M
1 round on record
Latest round
$2.3M
Venture round · Apr 2020 · 6 yr ago
Team
51-200
employees, estimated range
The money's age
Long since its last round
78 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Apr 2020 | $2.3M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Elgia Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Alan SaltielExecutive Officer, DirectorSEC Form D
Ariel FeldsteinExecutive Officer, DirectorSEC Form D
Thomas CollExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Light Horse is a small molecule drug discovery company that is leading the way in a.
SYNthesis Med Chem is a global provider of small molecule drug discovery services and offers a unique support to drug discovery projects.
Metanova Labs is an AI drug discovery company building a new model for discovering and developing novel therapeutics. Through NOVA, its…
Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that…
To find the right drug for the right target…. Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented…
Solutions for drug discovery and diagnostics. SPR analysis, antibody selection and LFA services. K-One sensor chips & bioconjugates supply.
Overview
Novel therapies for metabolic inflammation and fibrosisThe Elgia team has discovered how metabolic stress drives inflammation and fibrosis and has identified untapped protein targets for small molecule drug discovery.
People
Alan Saltiel
Executive Officer, Director
Ariel Feldstein
Executive Officer, Director
Thomas Coll
Executive Officer
Brian Hubbard
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Diego
United States
HQ
50-200 est. staff
Financials
Total raised
$2.3M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2020 | $2.3M | Details |